We utilized CD8+ T cells expressing the OT-I transgenic receptor, which specifically targets cells presenting the OVA-derived SIINFEKL antigen in the context of H-2kb and co-cultured them with SIINFEKL-pulsed EL4 cancer cells (Fig. S11). This evidence concerns the gene CD8A and cancer.